XELLIA PHARMS APS FDA Approval ANDA 205356

ANDA 205356

XELLIA PHARMS APS

FDA Drug Application

Application #205356

Documents

Letter2015-06-02

Application Sponsors

ANDA 205356XELLIA PHARMS APS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 150MG BASE/VIAL0COLISTIMETHATE SODIUMCOLISTIMETHATE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2015-05-29STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

XELLIA PHARMS APS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205356
            [companyName] => XELLIA PHARMS APS
            [docInserts] => ["",""]
            [products] => [{"drugName":"COLISTIMETHATE SODIUM","activeIngredients":"COLISTIMETHATE SODIUM","strength":"EQ 150MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/29\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/205356Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-05-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.